Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 8 of 8 entries
Sorted by: Best Match Show Resources per page
Pain in cancer survivors.

British journal of pain

Brown MR, Ramirez JD, Farquhar-Smith P.
PMID: 26516548
Br J Pain. 2014 Nov;8(4):139-53. doi: 10.1177/2049463714542605.

Cancer and its treatment exert a heavy psychological and physical toll. Of the myriad symptoms which result, pain is common, encountered in between 30% and 60% of cancer survivors. Pain in cancer survivors is a major and growing problem,...

Cite
Brown MR, Ramirez JD, Farquhar-Smith P. Pain in cancer survivors. Br J Pain. 2014;8(4):139-53doi: 10.1177/2049463714542605.
Brown, M. R., Ramirez, J. D., & Farquhar-Smith, P. (2014). Pain in cancer survivors. British journal of pain, 8(4), 139-53. https://doi.org/10.1177/2049463714542605
Brown, Matthew Rd, et al. "Pain in cancer survivors." British journal of pain vol. 8,4 (2014): 139-53. doi: https://doi.org/10.1177/2049463714542605
Brown MR, Ramirez JD, Farquhar-Smith P. Pain in cancer survivors. Br J Pain. 2014 Nov;8(4):139-53. doi: 10.1177/2049463714542605. PMID: 26516548; PMCID: PMC4616728.
Copy Download .nbib Format: NLM
Neuraxial (epidural and intrathecal) opioids for intractable pain.

British journal of pain

Farquhar-Smith P, Chapman S.
PMID: 26516463
Br J Pain. 2012 Feb;6(1):25-35. doi: 10.1177/2049463712439256.

1. Neuraxial opioids are considered for use in patients who have resistant intractable pain that fails to respond to other treatment options or pain that responds to analgesia but for which the doses required result in unacceptable side-effects. 2....

Cite
Farquhar-Smith P, Chapman S. Neuraxial (epidural and intrathecal) opioids for intractable pain. Br J Pain. 2012;6(1):25-35doi: 10.1177/2049463712439256.
Farquhar-Smith, P., & Chapman, S. (2012). Neuraxial (epidural and intrathecal) opioids for intractable pain. British journal of pain, 6(1), 25-35. https://doi.org/10.1177/2049463712439256
Farquhar-Smith, Paul, and Chapman, Suzanne. "Neuraxial (epidural and intrathecal) opioids for intractable pain." British journal of pain vol. 6,1 (2012): 25-35. doi: https://doi.org/10.1177/2049463712439256
Farquhar-Smith P, Chapman S. Neuraxial (epidural and intrathecal) opioids for intractable pain. Br J Pain. 2012 Feb;6(1):25-35. doi: 10.1177/2049463712439256. PMID: 26516463; PMCID: PMC4590095.
Copy Download .nbib Format: NLM
Quality of transition to end-of-life care for cancer patients in the intensive care unit.

Annals of intensive care

Miller SJ, Desai N, Pattison N, Droney JM, King A, Farquhar-Smith P, Gruber PC.
PMID: 26205668
Ann Intensive Care. 2015 Dec;5(1):59. doi: 10.1186/s13613-015-0059-7. Epub 2015 Jul 25.

BACKGROUND: There have been few studies that have evaluated the quality of end-of-life care (EOLC) for cancer patients in the ICU. The aim of this study was to explore the quality of transition to EOLC for cancer patients in...

Cite
Miller SJ, Desai N, Pattison N, et al. Quality of transition to end-of-life care for cancer patients in the intensive care unit. Ann Intensive Care. 2015;5(1):59doi: 10.1186/s13613-015-0059-7.
Miller, S. J., Desai, N., Pattison, N., Droney, J. M., King, A., Farquhar-Smith, P., & Gruber, P. C. (2015). Quality of transition to end-of-life care for cancer patients in the intensive care unit. Annals of intensive care, 5(1), 59. https://doi.org/10.1186/s13613-015-0059-7
Miller, Sophie J, et al. "Quality of transition to end-of-life care for cancer patients in the intensive care unit." Annals of intensive care vol. 5,1 (2015): 59. doi: https://doi.org/10.1186/s13613-015-0059-7
Miller SJ, Desai N, Pattison N, Droney JM, King A, Farquhar-Smith P, Gruber PC. Quality of transition to end-of-life care for cancer patients in the intensive care unit. Ann Intensive Care. 2015 Dec;5(1):59. doi: 10.1186/s13613-015-0059-7. Epub 2015 Jul 25. PMID: 26205668; PMCID: PMC4513017.
Copy Download .nbib Format: NLM
Pain in the Cancer Survivor.

Cancer treatment and research

Brown MRD, Farquhar-Smith P, Magee DJ.
PMID: 34542876
Cancer Treat Res. 2021;182:57-84. doi: 10.1007/978-3-030-81526-4_5.

Recent decades have demonstrated significant strides in cancer screening, diagnostics and therapeutics. As such there have been dramatic changes in survival following a diagnosis of cancer.

Cite
Brown MRD, Farquhar-Smith P, Magee DJ. Pain in the Cancer Survivor. Cancer Treat Res. 2021;182:57-84doi: 10.1007/978-3-030-81526-4_5.
Brown, M. R. D., Farquhar-Smith, P., & Magee, D. J. (2021). Pain in the Cancer Survivor. Cancer treatment and research, 18257-84. https://doi.org/10.1007/978-3-030-81526-4_5
Brown, Matthew R D, et al. "Pain in the Cancer Survivor." Cancer treatment and research vol. 182 (2021): 57-84. doi: https://doi.org/10.1007/978-3-030-81526-4_5
Brown MRD, Farquhar-Smith P, Magee DJ. Pain in the Cancer Survivor. Cancer Treat Res. 2021;182:57-84. doi: 10.1007/978-3-030-81526-4_5. PMID: 34542876.
Copy Download .nbib Format: NLM
Clinical practice guidelines for cancer pain: problems and solutions.

Current opinion in supportive and palliative care

Farquhar-Smith P.
PMID: 33843763
Curr Opin Support Palliat Care. 2021 Jun 01;15(2):84-90. doi: 10.1097/SPC.0000000000000550.

PURPOSE OF REVIEW: Clinical practice guidelines (CPGs) should allow practitioners to follow the best evidence-based management for patients. The increasing specialisation of medicine and pain medicine has increased the number of CPGs, but practitioners are still facing contradictory advice...

Cite
Farquhar-Smith P. Clinical practice guidelines for cancer pain: problems and solutions. Curr Opin Support Palliat Care. 2021;15(2):84-90doi: 10.1097/SPC.0000000000000550.
Farquhar-Smith, P. (2021). Clinical practice guidelines for cancer pain: problems and solutions. Current opinion in supportive and palliative care, 15(2), 84-90. https://doi.org/10.1097/SPC.0000000000000550
Farquhar-Smith, Paul. "Clinical practice guidelines for cancer pain: problems and solutions." Current opinion in supportive and palliative care vol. 15,2 (2021): 84-90. doi: https://doi.org/10.1097/SPC.0000000000000550
Farquhar-Smith P. Clinical practice guidelines for cancer pain: problems and solutions. Curr Opin Support Palliat Care. 2021 Jun 01;15(2):84-90. doi: 10.1097/SPC.0000000000000550. PMID: 33843763.
Copy Download .nbib Format: NLM
Is tapentadol different from classical opioids? A review of the evidence.

British journal of pain

Langford RM, Knaggs R, Farquhar-Smith P, Dickenson AH.
PMID: 27867511
Br J Pain. 2016 Nov;10(4):217-221. doi: 10.1177/2049463716657363. Epub 2016 Jul 25.

Tapentadol is a single molecule able to deliver analgesia by two distinct mechanisms, a feature which differentiates it from many other analgesics. Pre-clinical data demonstrate two mechanisms of action: mu-opioid receptor agonist activity and noradrenaline re-uptake inhibition. From these,...

Cite
Langford RM, Knaggs R, Farquhar-Smith P, et al. Is tapentadol different from classical opioids? A review of the evidence. Br J Pain. 2016;10(4):217-221doi: 10.1177/2049463716657363.
Langford, R. M., Knaggs, R., Farquhar-Smith, P., & Dickenson, A. H. (2016). Is tapentadol different from classical opioids? A review of the evidence. British journal of pain, 10(4), 217-221. https://doi.org/10.1177/2049463716657363
Langford, Richard M, et al. "Is tapentadol different from classical opioids? A review of the evidence." British journal of pain vol. 10,4 (2016): 217-221. doi: https://doi.org/10.1177/2049463716657363
Langford RM, Knaggs R, Farquhar-Smith P, Dickenson AH. Is tapentadol different from classical opioids? A review of the evidence. Br J Pain. 2016 Nov;10(4):217-221. doi: 10.1177/2049463716657363. Epub 2016 Jul 25. PMID: 27867511; PMCID: PMC5102094.
Copy Download .nbib Format: NLM
Gabapentin enacarbil extended release for the treatment of postherpetic neuralgia in adults.

Therapeutics and clinical risk management

Thomas BM, Farquhar-Smith P.
PMID: 24353426
Ther Clin Risk Manag. 2013;9:469-75. doi: 10.2147/TCRM.S50212. Epub 2013 Nov 25.

The development of biomedical technology is allowing refinement of drug therapies in order to improve medication profiles and benefit patients. Gabapentin (Gp) is a medication licensed globally for various indications, including postherpetic neuralgia. It has a pharmacokinetic profile which...

Cite
Thomas BM, Farquhar-Smith P. Gabapentin enacarbil extended release for the treatment of postherpetic neuralgia in adults. Ther Clin Risk Manag. 2013;9:469-75doi: 10.2147/TCRM.S50212.
Thomas, B. M., & Farquhar-Smith, P. (2013). Gabapentin enacarbil extended release for the treatment of postherpetic neuralgia in adults. Therapeutics and clinical risk management, 9469-75. https://doi.org/10.2147/TCRM.S50212
Thomas, Ben M, and Farquhar-Smith, Paul. "Gabapentin enacarbil extended release for the treatment of postherpetic neuralgia in adults." Therapeutics and clinical risk management vol. 9 (2013): 469-75. doi: https://doi.org/10.2147/TCRM.S50212
Thomas BM, Farquhar-Smith P. Gabapentin enacarbil extended release for the treatment of postherpetic neuralgia in adults. Ther Clin Risk Manag. 2013;9:469-75. doi: 10.2147/TCRM.S50212. Epub 2013 Nov 25. PMID: 24353426; PMCID: PMC3861364.
Copy Download .nbib Format: NLM
Guest Editorial.

British journal of pain

Farquhar-Smith P, Bennett M.
PMID: 26516544
Br J Pain. 2014 Nov;8(4):129. doi: 10.1177/2049463714555888.

No abstract available.

Cite
Farquhar-Smith P, Bennett M. Guest Editorial. Br J Pain. 2014;8(4):129doi: 10.1177/2049463714555888.
Farquhar-Smith, P., & Bennett, M. (2014). Guest Editorial. British journal of pain, 8(4), 129. https://doi.org/10.1177/2049463714555888
Farquhar-Smith, Paul, and Bennett, Mike. "Guest Editorial." British journal of pain vol. 8,4 (2014): 129. doi: https://doi.org/10.1177/2049463714555888
Farquhar-Smith P, Bennett M. Guest Editorial. Br J Pain. 2014 Nov;8(4):129. doi: 10.1177/2049463714555888. PMID: 26516544; PMCID: PMC4616724.
Copy Download .nbib Format: NLM
Showing 1 to 8 of 8 entries